Compare LYRA & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYRA | JCSE |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 5.9M |
| IPO Year | 2020 | 2022 |
| Metric | LYRA | JCSE |
|---|---|---|
| Price | $3.47 | $1.09 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 35.1K | 4.6K |
| Earning Date | 11-12-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 8.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $600,000.00 | ★ $11,804,296.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $93.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.84 | $0.86 |
| 52 Week High | $37.50 | $1.75 |
| Indicator | LYRA | JCSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 43.82 |
| Support Level | $3.51 | $1.05 |
| Resistance Level | $4.04 | $1.12 |
| Average True Range (ATR) | 0.33 | 0.04 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 39.62 | 17.49 |
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.